Rates and determinants of hepatitis B ‘e’ antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus

Boyd, Anders; Gozlan, Joël; Miailhes, Patrick; More

AIDS . 29(15):1963-1973, September 24, 2015.

Increased carotid intima–media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients

Goulenok, Tiphaine; Boyd, Anders; Larsen, Martin; More

AIDS . 29(3):287-293, January 28, 2015.

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

Desvarieux, Moïse; Boccara, Franck; Meynard, Jean-Luc; More

AIDS . 27(16):2603-2614, October 23, 2013.

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

Lacombe, Karine; Valin, Nadia; Stitou, Hind; More

AIDS . 27(8):1356-1359, May 15, 2013.

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV–hepatitis B virus-infected patients

Maylin, Sarah; Boyd, Anders; Lavocat, Fabien; More

AIDS . 26(8):939-949, May 15, 2012.

Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

Lacombe, Karine; Boyd, Anders; Desvarieux, Moise; More

AIDS . 21(18):2546-2549, November 30, 2007.